UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000038323
Receipt No. R000043677
Scientific Title Verification of intestinal environment improvement by amazake intake
Date of disclosure of the study information 2019/10/18
Last modified on 2020/08/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Verification of intestinal environment improvement by amazake intake
Acronym Verification of intestinal environment improvement by amazake intake
Scientific Title Verification of intestinal environment improvement by amazake intake
Scientific Title:Acronym Verification of intestinal environment improvement by amazake intake
Region
Japan

Condition
Condition Not applicable
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To verify intestinal environment improvement function of amazake
Basic objectives2 Others
Basic objectives -Others To examine how the habit of drinking amazake affects the intestinal environment (intensional bacterial flora) that changes with the medication of mild constipation.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes alteration of intensional bacterial flora
Key secondary outcomes Bowel movement

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 4
Purpose of intervention Educational,Counseling,Training
Type of intervention
Food
Interventions/Control_1 Amazake made by rice koji is taken once a day for 4 weeks
Interventions/Control_2 Placebo drink of control 1 is taken once a day for 4 weeks
Interventions/Control_3 Amazake made by rice koji and sake lees is taken once a day for 4 weeks
Interventions/Control_4 Placebo drink of control 3 is taken once a day for 4 weeks
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >
Gender Male and Female
Key inclusion criteria 1) Regular visitor of Matsuo Clinic
2) Women with mild constipation who are prescribed magnesium oxide whose age at the time of obtaining consent to participate in the study is 20 to 60 years old (20 to 60 years old)
3) Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, volunteered to participate voluntarily after understanding well, and can agree to participate in this study in writing
4) Those who can visit the hospital on the designated day and can receive an inquiry
5) Those who are deemed appropriate by the study investigator to participate in this study
Key exclusion criteria 1) Persons with symptoms other than mild constipation
2) Persons who have no visit history for the past 3 months
3) Those who cannot be judged by the investigator without affecting the participation in the study
4) Those who may cause allergic symptoms to ingredients in test food
5) People who drink amazake (regardless of manufacturer)
6) Those who plan to become pregnant, breast-feeding, or possibly pregnant, and pregnant during the study period
7) Persons with alcoholism or other mental disorders
8) Persons who may change their lifestyle during the test period (night work, long trip, etc.)
9) Those who are planning to take health functional foods or supplement foods during the study period
10) Those who have been treated with hospitalization within the past 6 months
11) Persons currently participating in other human clinical trials, those who have not passed 3 months since participating in other human clinical trials
12) Other persons who are deemed inappropriate by the study investigator
Target sample size 20

Research contact person
Name of lead principal investigator
1st name sadao
Middle name
Last name mori
Organization MORINAGA & CO., LTD.
Division name R & D Center
Zip code 230-8504
Address 2-1-1 Shimosueyoshi Turumi-ku Yokohama, Kanagawa
TEL 045-571-6140
Email s-mori-ab@morinaga.co.jp

Public contact
Name of contact person
1st name sadao
Middle name
Last name mori
Organization MORINAGA & CO., LTD.
Division name R & D Center
Zip code 230-8504
Address 2-1-1 Shimosueyoshi Turumi-ku Yokohama, Kanagawa
TEL 045-571-6140
Homepage URL
Email s-mori-ab@morinaga.co.jp

Sponsor
Institute MORINAGA & CO., LTD.
Institute
Department

Funding Source
Organization MORINAGA & CO., LTD.
R & D Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Matsuike Clinic
Name of secondary funder(s)

IRB Contact (For public release)
Organization NPO MINS
Address 401 5-20-9 mita minato-ku Tokyo
Tel 03-6416-1868
Email 03-6416-1869

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 松生クリニック

Other administrative information
Date of disclosure of the study information
2019 Year 10 Month 18 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications http://lifescience.co.jp/yk/yk20/ykj2007.html
Number of participants that the trial has enrolled 25
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2019 Year 09 Month 19 Day
Date of IRB
2019 Year 09 Month 19 Day
Anticipated trial start date
2019 Year 10 Month 17 Day
Last follow-up date
2020 Year 01 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 10 Month 17 Day
Last modified on
2020 Year 08 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043677

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.